PDCD1LG2 and myeloid sarcoma: One study showed that the expressions of miR-1, miR-20a, miR-28, miR-95, miR-146a, miR-335, and miR-625 in the PBMC of pregnant MS patients were downregulated, while the levels of IL10, PDL1, and PDL2 were increased compared with untreated MS patients.